Literature DB >> 36056201

Optimization of Meloxicam Solid Dispersion Formulations for Dissolution Enhancement and Storage Stability Using 33 Full Factorial Design Based on Response Surface Methodology.

Maha F Emam1, Ahmed A El-Ashmawy2, Nadia M Mursi3, Laila H Emara2.   

Abstract

This study aimed to formulate and optimize solid-dispersion of meloxicam (MX) employing response-surface-methodology (RSM). RSM allowed identification of the main effects and interactions between studied factors on MX dissolution and acceleration of the optimization process. 33 full factorial design with 27 different formulations was proposed. Effects of drug loading percentage (A), carriers' ratio (B), method of preparation (C), and their interactions on percent MX dissolved after 10 and 30 min (Q10min & Q30min) from fresh and stored samples were studied in distilled water. The considered levels were 2.5%, 5.0%, and 7.5% (factor A), three ratios of Soluplus®/Poloxamer-407 (factor B). Physical mixture (PM), fusion method (FM), and hot-melt-extrusion (HME) were considered factor (C). Stability studies were carried out for 3 months under stress conditions. The proposed optimization design was validated by 3-extra checkpoints formulations. The optimized formulation was selected via numerical optimization and investigated by DSC, XRD, PLM, and in vitro dissolution study. Results showed that HME technique gave the highest MX dissolution rate compared to other techniques (FM & PM). At constant level of factor (C), the amount of MX dissolved increased by decreasing MX loading and increasing Soluplus in carriers' ratio. Actual responses of the optimized formulation were in close consistency with predicted data. Amorphous form of MX in the optimized formulation was proved by DSC, XRD, and PLM. Selected factors and their levels of the optimization design were significantly valuable for demonstrating and adapting the expected formulation characteristics for rapid dissolution of MX (Q10min= 89.09%) from fresh and stored samples.
© 2022. The Author(s).

Entities:  

Keywords:  33 full factorial design; Soluplus/Poloxamer-407; hot-melt extrusion (HME); meloxicam; response surface methodology (RSM)

Mesh:

Substances:

Year:  2022        PMID: 36056201     DOI: 10.1208/s12249-022-02394-7

Source DB:  PubMed          Journal:  AAPS PharmSciTech        ISSN: 1530-9932            Impact factor:   4.026


  31 in total

Review 1.  Amorphous solid dispersions: Rational selection of a manufacturing process.

Authors:  Teófilo Vasconcelos; Sara Marques; José das Neves; Bruno Sarmento
Journal:  Adv Drug Deliv Rev       Date:  2016-01-27       Impact factor: 15.470

Review 2.  Review: physical chemistry of solid dispersions.

Authors:  Sandrien Janssens; Guy Van den Mooter
Journal:  J Pharm Pharmacol       Date:  2009-12       Impact factor: 3.765

3.  Characterization of physico-mechanical properties of indomethacin and polymers to assess their suitability for hot-melt extrusion processs as a means to manufacture solid dispersion/solution.

Authors:  Rina J Chokshi; Harpreet K Sandhu; Raman M Iyer; Navnit H Shah; A Waseem Malick; Hossein Zia
Journal:  J Pharm Sci       Date:  2005-11       Impact factor: 3.534

Review 4.  Hot-Melt Extrusion: from Theory to Application in Pharmaceutical Formulation.

Authors:  Hemlata Patil; Roshan V Tiwari; Michael A Repka
Journal:  AAPS PharmSciTech       Date:  2015-07-10       Impact factor: 3.246

5.  Effect of plasticizers on manufacturing ritonavir/copovidone solid dispersions via hot-melt extrusion: Preformulation, physicochemical characterization, and pharmacokinetics in rats.

Authors:  Yanna Zhao; Xuemei Xie; Yuping Zhao; Yan Gao; Chang Cai; Qinxiu Zhang; Zhuang Ding; Zhiping Fan; Huaizhen Zhang; Min Liu; Jun Han
Journal:  Eur J Pharm Sci       Date:  2018-10-19       Impact factor: 4.384

6.  Amorphous solid dispersions of darunavir: Comparison between spray drying and electrospraying.

Authors:  Annelies Smeets; Robin Koekoekx; Christian Clasen; Guy Van den Mooter
Journal:  Eur J Pharm Biopharm       Date:  2018-06-19       Impact factor: 5.571

7.  Hot Melt Extrusion and Spray Drying of Co-amorphous Indomethacin-Arginine With Polymers.

Authors:  Elisabeth Lenz; Korbinian Löbmann; Thomas Rades; Klaus Knop; Peter Kleinebudde
Journal:  J Pharm Sci       Date:  2016-11-03       Impact factor: 3.534

8.  Hot Melt Extrusion as Solvent-Free Technique for a Continuous Manufacturing of Drug-Loaded Mesoporous Silica.

Authors:  Natalja Genina; Batol Hadi; Korbinian Löbmann
Journal:  J Pharm Sci       Date:  2017-06-08       Impact factor: 3.534

9.  Preparation of carbamazepine-Soluplus solid dispersions by hot-melt extrusion, and prediction of drug-polymer miscibility by thermodynamic model fitting.

Authors:  Jelena Djuris; Ioannis Nikolakakis; Svetlana Ibric; Zorica Djuric; Kyriakos Kachrimanis
Journal:  Eur J Pharm Biopharm       Date:  2013-01-18       Impact factor: 5.571

10.  Fusion production of solid dispersions containing a heat-sensitive active ingredient by hot melt extrusion and Kinetisol dispersing.

Authors:  James C Dinunzio; Chris Brough; Justin R Hughey; Dave A Miller; Robert O Williams; James W McGinity
Journal:  Eur J Pharm Biopharm       Date:  2009-10-07       Impact factor: 5.571

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.